end-stage renal disease and renal replacement therapy in older patients
نویسندگان
چکیده
as the world’s population continues to age, practitioners encounter increasing numbers of older patients with end-stage renal disease (esrd) who require renal replacement therapy (rrt). conservative management may be considered in older patients and has been shown to offer comparable survival rates and hospital-free days to rrt patients. at present, for those who choose rrt, hemodialysis is the most commonly used modality. many practitioners believe that peritoneal dialysis (pd), including assisted peritoneal dialysis, can be used safely in this population. age is not a contra-indication to peritoneal dialysis, and a choice of modality should be offered to older patients. assisted peritoneal dialysis has been used successfully in multiple regions without an increase in complication rates. quality of life is an important issue for older patients with esrd, and studies such as broadening options for long-term dialysis in the elderly support the use of pd in older patients as it is associated with fewer fluctuations in symptoms of esrd and less intrusion into people’s lives. this review discusses the appropriateness of initiating rrt in older patients, choices of modality, underutilization of pd in older patients, use of assisted pd, complication rates, and quality of life in these patients. overall, pd seems to be a safe and effective modality of rrt in older patients, and assisted pd can be used in patients with limited functional impairment.
منابع مشابه
End-Stage Renal Disease and Renal Replacement Therapy in older Patients
As the world's population continues to age, practitioners encounter increasing numbers of older patients with end-stage renal disease (ESRD) who require renal replacement therapy (RRT). Conservative management may be considered in older patients and has been shown to offer comparable survival rates and hospital-free days to RRT patients. At present, for those who choose RRT, hemodialysis is the...
متن کاملRenal replacement therapy in Latin American end-stage renal disease
The Latin American Dialysis and Renal Transplant Registry (RLADTR) was founded in 1991; it collects data from 20 countries which are members of Sociedad Latinoamericana de Nefrología e Hipertension. This paper presents the results corresponding to the year 2010. This study is an annual survey requesting data on incident and prevalent patients undergoing renal replacement treatment (RRT) in all ...
متن کاملRenal replacement therapy in patients with diabetes and end-stage renal disease.
The number of patients who have diabetes and ESRD and are being admitted to renal replacement treatment (RRT) is increasing dramatically worldwide, and in many countries, diabetes has become the single most frequent cause of ESRD. Although the prognosis of patients who have diabetes and are receiving RRT has greatly improved, survival and medical rehabilitation rates continue to be significantl...
متن کاملRenal replacement therapy in geriatric end-stage renal disease patients: a clinical approach.
The number of geriatric patients on dialysis is increasing. This is due to demographic factors, a wider acceptance of elderly patients on dialysis, and an earlier start of dialysis in this patient group. Recent studies have questioned the effect of dialysis on quality of life in elderly patients with severe comorbidity and showed limited survival in this specific patient group. Therefore, the d...
متن کاملChoice of renal replacement therapy in patients with diabetic end stage renal disease.
Diabetic nephropathy is becoming the leading cause of end-stage renal disease (ESRD) worldwide. Although the prognosis of patients with diabetes and ESRD receiving Renal Replacement Therapy (RRT) has improved greatly, the presence of pre-existing cardiovascular disease means that the survival and medical rehabilitation of diabetics continue to be inferior to that of non-diabetics. RRT should be...
متن کاملThe relationship between Aldosterone level and various LV conditions in patients with End-stage renal disease
Background: Aldosterone has been assumed to be implicated in left ventricular hypertrophy (LVH). Preventing the progression of LVH in the early period of end-stage renal disease (ESRD) can increase patient survival. In this study, therefore, we analyzed the relationship between aldosterone level and LVH in ESRD patients who underwent hemodialysis at Fatemeh Zahra Hospital and Imam Khomeini Hosp...
متن کاملمنابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
عنوان ژورنال:
nephro-urology monthlyجلد ۴، شماره ۲، صفحات ۴۲۵-۴۳۰
کلمات کلیدی
میزبانی شده توسط پلتفرم ابری doprax.com
copyright © 2015-2023